Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STAMPOUT: Study of Antibody for Methamphetamine Outpatient Therapy

NCT03336866 is registered in ClinicalTrials.gov with InterveXion Therapeutics, LLC as lead sponsor.

NCT NCT03336866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STAMPOUT: Study of Antibody for Methamphetamine Outpatient Therapy
Lead sponsor
InterveXion Therapeutics, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
May 3, 2018
Completion date
March 9, 2021
Enrollment
77 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

methamphetamine abuse, methamphetamine-dependence